Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
-
New psoriasis pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an experimental pill called D-2570 in 161 adults with moderate-to-severe plaque psoriasis. Participants took the pill or a placebo daily for 12 weeks. The main goal was to see if the pill could clear at least 75% of skin plaques. Results are being analyzed to de…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New drug D-2570 takes first step: safety check in 100 healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called D-2570 in 100 healthy adults aged 18 to 45. Participants received either the drug or a placebo, and researchers monitored side effects, vital signs, and drug levels in the blood. The goal was to g…
Phase: PHASE1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC